Literature DB >> 2865679

Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders.

E P Palmer, A T Guay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865679     DOI: 10.1056/NEJM198512053132306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Emetine-induced myopathy and carnitine deficiency.

Authors:  T Kuntzer; H Reichmann; J Bogousslavsky; F Regli
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Myopathy from surreptitious ipecac ingestion.

Authors:  N L Rosenberg; S P Ringel
Journal:  West J Med       Date:  1986-09

3.  Cardiotoxicity of emetine dihydrochloride by calcium channel blockade in isolated preparations and ventricular myocytes of guinea-pig hearts.

Authors:  R Lemmens-Gruber; A Karkhaneh; C Studenik; P Heistracher
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 4.  Detection, evaluation, and treatment of eating disorders the role of the primary care physician.

Authors:  J M Walsh; M E Wheat; K Freund
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

Review 5.  Toxicity of weight loss agents.

Authors:  May Yen; Michele Burns Ewald
Journal:  J Med Toxicol       Date:  2012-06

6.  Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies.

Authors:  N J Hopf; H H Goebel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

8.  Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

Authors:  T Kuntzer; J Bogousslavsky; J P Deruaz; R Janzer; F Regli
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.